2022
DOI: 10.1016/j.suronc.2022.101840
|View full text |Cite
|
Sign up to set email alerts
|

Sublobar resection without staging and lymphadenectomy for ≤2 cm Non-Small Cell Lung Cancer is no adequate therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…Many articles have compared the clinical performances of lobar vs. sublobar surgery in early-stage lung cancer, and recent data suggest that the second approach is superior in small-sized lung cancer (<2.0 cm in diameter with a relevant ground glass component) [ 4 , 5 , 24 , 25 , 26 ]. Although these results have created great interest among oncologists and surgeons and are going to change clinical practice, some details still need to be clarified.…”
Section: Discussionmentioning
confidence: 99%
“…Many articles have compared the clinical performances of lobar vs. sublobar surgery in early-stage lung cancer, and recent data suggest that the second approach is superior in small-sized lung cancer (<2.0 cm in diameter with a relevant ground glass component) [ 4 , 5 , 24 , 25 , 26 ]. Although these results have created great interest among oncologists and surgeons and are going to change clinical practice, some details still need to be clarified.…”
Section: Discussionmentioning
confidence: 99%
“…Schlachtenberger et al reported that 16.5% of patients with NSCLC ≤2 cm had lymph node upstage after surgery. It was emphasized that lymph node dissection and proper staging are important for resected NSCLC patients, regardless of tumor size or surgical approach ( 26 ).…”
Section: Methodsmentioning
confidence: 99%